tradingkey.logo
tradingkey.logo

TELA Bio Inc

TELA
1.130USD
-0.010-0.88%
終値 12/19, 16:00ET15分遅れの株価
45.59M時価総額
損失額直近12ヶ月PER

TELA Bio Inc

1.130
-0.010-0.88%

詳細情報 TELA Bio Inc 企業名

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

TELA Bio Incの企業情報

企業コードTELA
会社名TELA Bio Inc
上場日Nov 08, 2019
最高経営責任者「CEO」Koblish (Antony)
従業員数209
証券種類Ordinary Share
決算期末Nov 08
本社所在地1 Great Valley Parkway, Suite 24
都市MALVERN
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号19355
電話番号14843202930
ウェブサイトhttps://www.telabio.com/
企業コードTELA
上場日Nov 08, 2019
最高経営責任者「CEO」Koblish (Antony)

TELA Bio Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+126.79%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
11.93K
--
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. William Plovanic
Mr. William Plovanic
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-21.60%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+1318.24%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-27.72%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+126.79%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+126.79%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+126.79%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
事業別USD
会社名
収益
比率
OviTex
24.60M
63.53%
OviTex PRS
13.38M
34.55%
Other
744.00K
1.92%
会社から関連データがまだ開示されていません。
事業別
地域別
事業別USD
会社名
収益
比率
OviTex
24.60M
63.53%
OviTex PRS
13.38M
34.55%
Other
744.00K
1.92%

株主

更新時刻: Sat, Nov 15
更新時刻: Sat, Nov 15
株主統計
種類
株主統計
株主統計
比率
EW Healthcare Partners
17.62%
Nantahala Capital Management, LLC
11.68%
North Run Capital, LP
8.41%
Lytton (Laurence W)
6.55%
SilverArc Capital Management, LLC
6.36%
他の
49.38%
株主統計
株主統計
比率
EW Healthcare Partners
17.62%
Nantahala Capital Management, LLC
11.68%
North Run Capital, LP
8.41%
Lytton (Laurence W)
6.55%
SilverArc Capital Management, LLC
6.36%
他の
49.38%
種類
株主統計
比率
Hedge Fund
33.32%
Venture Capital
17.62%
Investment Advisor
9.79%
Investment Advisor/Hedge Fund
8.67%
Individual Investor
8.59%
Research Firm
1.77%
他の
20.24%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
171
28.74M
72.54%
-9.88M
2025Q2
185
33.40M
84.44%
-6.87M
2025Q1
191
33.22M
84.09%
-7.97M
2024Q4
187
31.75M
80.76%
+976.11K
2024Q3
178
22.55M
84.95%
-6.37M
2024Q2
170
20.61M
83.03%
-5.54M
2024Q1
157
22.19M
89.70%
-5.95M
2023Q4
151
21.96M
89.44%
-4.89M
2023Q3
146
22.32M
90.91%
-4.91M
2023Q2
142
22.34M
91.32%
+1.25M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
EW Healthcare Partners
4.11M
10.38%
--
--
Jun 30, 2025
Nantahala Capital Management, LLC
5.11M
12.9%
-1.00
-0.00%
Jun 30, 2025
North Run Capital, LP
3.68M
9.3%
+1.70M
+85.75%
Mar 31, 2025
Lytton (Laurence W)
2.72M
6.88%
+271.93K
+11.09%
Jun 30, 2025
SilverArc Capital Management, LLC
2.78M
7.02%
+8.51K
+0.31%
Jun 30, 2025
Stonepine Capital Management, LLC
2.08M
5.26%
+28.54K
+1.39%
Jun 30, 2025
The Vanguard Group, Inc.
1.91M
4.83%
-16.59K
-0.86%
Jun 30, 2025
Dafna Capital Management, LLC
1.44M
3.64%
--
--
Jun 30, 2025
Perkins Capital Management, Inc.
875.87K
2.21%
-34.75K
-3.82%
Jun 30, 2025
Citi Investment Research (US)
750.00K
1.89%
--
--
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
比率0.01%
ProShares Hedge Replication ETF
比率0%
iShares Russell 2000 Growth ETF
比率0%
iShares Russell 2000 ETF
比率0%
Global X Russell 2000 ETF
比率0%
Global X Russell 2000 Covered Call ETF
比率0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0%
ProShares UltraPro Russell2000
比率0%
Proshares Ultra Russell 2000
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

TELA Bio Incの上位5名の株主は誰ですか?

TELA Bio Incの上位5名の株主は以下のとおりです。
EW Healthcare Partnersは4.11M株を保有しており、これは全体の10.38%に相当します。
Nantahala Capital Management, LLCは5.11M株を保有しており、これは全体の12.90%に相当します。
North Run Capital, LPは3.68M株を保有しており、これは全体の9.30%に相当します。
Lytton (Laurence W)は2.72M株を保有しており、これは全体の6.88%に相当します。
SilverArc Capital Management, LLCは2.78M株を保有しており、これは全体の7.02%に相当します。

TELA Bio Incの株主タイプ上位3種は何ですか?

TELA Bio Incの株主タイプ上位3種は、
EW Healthcare Partners
Nantahala Capital Management, LLC
North Run Capital, LP

TELA Bio Inc(TELA)の株式を保有している機関の数はいくつですか?

2025Q3時点で、TELA Bio Incの株式を保有している機関は171社あり、保有株式の総市場価値は約28.74Mで、全体の72.54%を占めています。2025Q2と比較して、機関の持ち株は-11.90%増加しています。

TELA Bio Incの最大の収益源は何ですか?

FY2025Q2において、OviTex部門がTELA Bio Incにとって最大の収益を生み出しており、その金額は24.60Mで、全収益の63.53%を占めています。
KeyAI